Veterinary Medicines

ORIBIOTIC

Authorised
  • NEOMYCIN SULFATE
  • Triamcinolone acetonide
  • Nystatin
Download as PDF

Product identification

Medicine name:
ORIBIOTIC
Active substance:
  • NEOMYCIN SULFATE
  • Triamcinolone acetonide
  • Nystatin
Target species:
  • Dog
  • Cat
Route of administration:
  • Auricular use

Product details

Active substance and strength:
  • NEOMYCIN SULFATE
    3500.00
    international unit(s)
    /
    1.00
    gram(s)
  • Triamcinolone acetonide
    1.00
    milligram(s)
    /
    1.00
    gram(s)
  • Nystatin
    100000.00
    international unit(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Ear ointment
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS02DC
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol S.A.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/2356421 5/1989
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download